中文
Since 2026, with the continuous recovery of research and development investment in the domestic pharmaceutical and new materials fields, the market demand for pyridinium p-toluenesulfonate as a classic catalyst has shown a steady growth trend. At the same time, the prices of upstream raw materials such as toluene sulfonic acid and pyridine remain fluctuating within a range due to environmental protection and energy costs, providing strong support for the cost side of this product.
From the perspective of supply pattern, the industrial production of PPTS requires high reaction processes and purification levels. The mainstream specifications currently circulating in the market are purity ≥ 99%, and high-purity products (≥ 99.5%) mainly serve the catalytic processes of peptide synthesis, nucleotide drugs, and complex chiral intermediates. It is worth noting that PPTS has strong hygroscopicity and has clear requirements for packaging materials and storage conditions – usually sealed in aluminum foil bags or fluoride bottles and stored in a cool and dry place. The different storage conditions also lead to differences in the free acid content between different batches. The purchaser should focus on the supplier’s quality control indicators, such as burn residue and heavy metal content.
Looking ahead to the future, with the continuous enrichment of global innovative drug research and development pipelines, especially the rigid demand for mild catalysts in nucleic acid drugs and ADC fields, PPTS’s industry position as a classic acidic catalyst will be further consolidated. It is recommended that the purchaser prioritize selecting supply channels with a sound quality inspection system and good batch stability, and plan the procurement cycle reasonably based on their own research and development progress. On the premise of controllable costs, locking in high-quality PPTS sources can help ensure the steady progress of the synthesis route.